MDMA Successfully Treats PTSD in Another Phase 3 Trial Sponsored by MAPS
“MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024,” says MAPS founder and president Rick Doblin.
rick doblin
Honest Thoughts from a Psychedelic Healer on the Psychedelic Science 2023 Summit
13,000 attendees may feel like a sea of change, but it is still a bubble in the bigger context of mainstream change.
Exclusive: Beckley Waves Establishes Ethics Council to Guide Psychedelic Industry Standards
Beckley Waves has formed a new Ethics Council.
The World Science Festival: Five Questions for Producer Caitlin Riley
We talk with producer Caitlin Riley about getting Rick Doblin and Reggie Watts to talk psychedelics at the World Science Festival
The Narrowing of Psychedelic Discourse
Psychedelic discourse was once filled with visions of infinite possibilities, but recently the conversation has turned to more mundane concerns
A Brief History of MDMA: From the CIA to Raves to Psychedelic Therapy
The history of MDMA is fascinating, and it is still being written.
MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA Trials
A sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader MAPS, currently being scrutinized by Health Canada.
How Rick Doblin Guides Someone Through a Bad Psychedelic Trip
Difficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
Driver’s Licenses to Trip on Psychedelics by 2035? Rick Doblin Maps Out the Future of ‘Spiritualized Humanity’
The MAPS founder, who will speak at psychedelic conference Wonderland Miami next month, predicts clinics that administer the medicines will become licensing bodies for personal use.
End of content
End of content